Deleted in liver cancer protein family in human malignancies (Review)
about
Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor geneCooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implicationsCRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growthFunctional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine fingerDLC1 is the principal biologically-relevant down-regulated DLC family member in several cancersThe tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell-cell adhesionCDK5 is a major regulator of the tumor suppressor DLC1The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.Regulation of white and brown adipocyte differentiation by RhoGAP DLC1.Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast CancersFKBP51 regulates cell motility and invasion via RhoA signaling.Filling GAPs in our knowledge: ARHGAP11A and RACGAP1 act as oncogenes in basal-like breast cancers.Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression.DLC2 inhibits development of glioma through regulating the expression ratio of TAp73α/TAp73β
P2860
Q27025409-E140B244-5A16-4CAD-80F7-4A361507A909Q28384501-6F333612-FAD3-42DF-8BB0-25990E33FECCQ28389945-14FF5EF1-4963-47A4-A56A-99C294C1FE6FQ28397100-F1E677D9-2FEF-470B-B821-789D25FA7859Q28397799-70279BEC-48D2-40B3-BD3C-C2E36A4FB872Q30613021-D4C7DE3B-C369-46D2-8381-B3F137BE49D3Q34656836-9EBFB9B4-EFD1-40B9-8A78-9066256D5877Q34980429-ECBE4783-1098-402F-B0D8-279378492DE4Q36328562-867EC5D6-D42F-4CF8-8396-0716B8D30196Q37059761-B13399DD-5929-4B36-A003-3408485D26A1Q38723837-CFE59F5A-FE2D-45F7-9AD0-50E39DFB00EDQ42499361-76BDE222-9F1E-4E33-A0C8-30215F8B5BD0Q47334214-6B050B0E-2669-483C-997C-A27646C657E8Q47428473-49A6DDF5-5411-4CFF-A1C4-A29ADBF231B8Q55079524-F058DB56-BA91-4990-8B31-019C80765A7DQ57071900-8AA382B9-3B43-43EC-B574-499701C61B8E
P2860
Deleted in liver cancer protein family in human malignancies (Review)
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Deleted in liver cancer protein family in human malignancies (Review)
@ast
Deleted in liver cancer protein family in human malignancies (Review)
@en
Deleted in liver cancer protein family in human malignancies (Review)
@nl
type
label
Deleted in liver cancer protein family in human malignancies (Review)
@ast
Deleted in liver cancer protein family in human malignancies (Review)
@en
Deleted in liver cancer protein family in human malignancies (Review)
@nl
prefLabel
Deleted in liver cancer protein family in human malignancies (Review)
@ast
Deleted in liver cancer protein family in human malignancies (Review)
@en
Deleted in liver cancer protein family in human malignancies (Review)
@nl
P2093
P2860
P3181
P356
P1433
P1476
Deleted in liver cancer protein family in human malignancies (Review)
@en
P2093
A Wasiutynski
B Gornicka
P2860
P304
P3181
P356
10.3892/OL.2011.345
P407
P577
2011-09-01T00:00:00Z